2024-03-29 | PROTMLST | Single | DECLINED TO CONTINUE INTO NEXT TRIAL ELEMENT | | C186210 | C114118 | | |
2024-03-29 | PROTMLST | Single | DECLINED TO CONTINUE INTO SURVIVAL FOLLOW-UP | | C176358 | C114118 | | |
2024-03-29 | PROTMLST | Single | ELIGIBILITY CRITERIA MET | | C132447 | C114118 | | |
2024-03-29 | PROTMLST | Single | ELIGIBILITY CRITERIA NOT MET | | C164344 | C114118 | | |
2024-03-29 | PROTMLST | Single | ENTERED INTO TRIAL | | C161417 | C114118 | | |
2024-03-29 | PROTMLST | Single | INFORMED ASSENT OBTAINED | | C161418 | C114118 | | |
2024-03-29 | PROTMLST | Single | INFORMED CONSENT DECLINED FOR PROTOCOL-SPECIFIED ACTIVITY | | C202445 | C114118 | | |
2024-03-29 | PROTMLST | Single | INFORMED CONSENT OBTAINED | | C16735 | C114118 | | |
2024-03-29 | PROTMLST | Single | INFORMED CONSENT OBTAINED FOR PROTOCOL-SPECIFIED ACTIVITY | | C202444 | C114118 | | |
2024-03-29 | PROTMLST | Single | OPTED TO CONTINUE INTO NEXT TRIAL ELEMENT | | C186211 | C114118 | | |
2024-03-29 | PROTMLST | Single | OPTED TO CONTINUE INTO SURVIVAL FOLLOW-UP | | C176357 | C114118 | | |
2024-03-29 | PROTMLST | Single | RANDOMIZED | | C114209 | C114118 | | |
2024-03-29 | PROTMLST | Single | RE-RANDOMIZED | | C186212 | C114118 | | |